13h
Aclarion Technology Demonstrates Potential Beyond Surgical Planning in New Immune-Biomarker Study
Award-winning, NIH funded study indicates that immune-associated biological signatures may play a role in some cases of back painNociscan’s ...
Aclarion, Inc., (“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW), a healthcare technology company that is leveraging biomarkers and proprietary augmented intelligence (AI) algorithms to help ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results